A clinical trial to study the effect of newer local anesthetic levobupivacaine in comparison with bupivacaine for spinal anesthesia.

Intrathecal levobupivacaine 0.5% versus Intrathecal bupivacaine 0.5% for spinal anesthesia.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2009/091/000736

Enrollment

200

Registered

2010-12-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Levobupivacaine: 3.5ml of 0.5% Control Intervention1: Bupivacaine: 3.5ml of 0.5%

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA Grade I and II. 2. Weight - 50 to 80 kg. 3. Height - 140 to 180 cm. 4. Age - 18 to 60 yrs. 5. Surgeries on the lower limbs, pelvis and lower abdomen.

Exclusion criteria

Exclusion criteria: 1. Patient?s refusal to participate in the study. 2. ASA Grade III, IV and V. 3. Age below 18 years and above 60 years. 4. Weight below 30 kg and above 80 kg. 5. Patients with history of allergy to any drug.

Design outcomes

Primary

Measure	Time frame
1.To study local anaesthetic efficacy of intrathecal levobupicaine with respect to a. Onset of action. b. Duration of action. c. Type of neural block. Timepoint: To compare bupivacaine and levobupivacaine with respect to above parameters	—

Secondary

Measure	Time frame
To evaluate whether levobupivacaine is a better long acting local anaesthetic as compared to bupivacaine.Timepoint: At the end of study and after statistical analysis.	—

Countries

India

Contacts

Public ContactDr Bharati Kondwilkar

bhartik2009@gmail.com022-23735555,2269

Outcome results